KWR Stock Cash Flow Statements

Quaker Chemical Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Quaker Chemical Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2020-03-31	2019-12-31	2019-06-30	2019-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30

cash flows from operating activities
net income	-66,563,000	12,917,000	14,189,000	32,372,000	34,910,000	35,258,000	20,228,000	33,710,000	29,393,000	29,541,000	-28,344,000	15,316,000	29,549,000	13,900,000	-9,359,000	11,704,000	12,341,000	7,614,000	16,351,000	15,405,000	13,344,000	14,835,000	15,412,000	10,607,000	15,942,000	13,309,000	14,680,000	13,305,000	16,675,000	14,191,000	15,193,000	11,184,000	11,170,000	12,693,000	10,310,000	13,805,000	10,555,000	11,230,000	7,463,000	6,857,000	9,734,000	10,037,000	8,373,000	5,423,000	3,492,000	202,000	-2,722,000	4,440,000	4,321,000	5,093,000	4,623,000	3,160,000	4,151,000	3,537,000	2,994,000	3,139,000	2,992,000	2,542,000	-5,445,000	2,212,000	1,795,000	3,126,000	1,664,000	1,154,000	2,847,000	3,309,000	4,115,000	4,136,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	23,679,000	20,599,000	20,960,000	21,175,000	21,182,000	20,802,000	20,553,000	20,610,000	20,578,000	20,246,000
equity in undistributed earnings of associated companies, net of dividends	2,725,000	-2,769,000	-3,778,000	5,266,000	-2,546,000	-1,675,000	-3,663,000	-3,279,000	194,000	-4,401,000															-1,004,000	-927,000	-1,637,000	-1,504,000	-1,942,000	921,000	-1,922,000	-257,000	-209,000	38,000						-290,000				-525,000				-191,000				-57,000	-70,000	44,000		-218,000	-125,000	92,000
deferred income taxes	-12,294,000	-3,340,000	-2,099,000																																															1,246,000	1,144,000	-1,950,000	91,000	361,000		500,000	695,000	-361,000
share-based compensation	3,721,000	3,182,000	2,578,000	4,285,000	4,244,000	3,884,000	3,416,000	3,775,000	3,887,000	3,527,000
impairment charges
restructuring and related charges	8,793,000	14,590,000	1,743,000	2,610,000	320,000	1,857,000			1,043,000	3,972,000
inventory step-up amortization
gain on disposal of property, plant and equipment and other assets
other adjustments	-7,418,000	2,190,000
increase in cash from changes in current assets and current liabilities, net of acquisitions:
accounts receivable	13,324,000	-10,302,000	4,350,000	10,142,000	9,052,000	1,431,000	10,036,000	116,000	25,991,000	-3,974,000															-7,176,000	-13,387,000	1,385,000	-3,309,000	-5,936,000	-3,977,000	2,160,000	5,650,000	2,733,000	-9,764,000			-4,914,000	-12,478,000	3,513,000	2,663,000	-7,039,000	-3,606,000	-7,767,000	-12,547,000	6,302,000	7,196,000	19,305,000	-4,736,000	-146,000	1,159,000	1,702,000	8,990,000	-4,152,000	-10,633,000	1,130,000	-1,331,000	-2,321,000	-6,425,000	-965,000	-6,154,000	1,270,000	-3,751,000	954,000	-2,491,000	-508,000	-4,316,000	-144,000	-3,080,000
inventories	1,631,000	-13,457,000	7,631,000	-1,734,000	-2,565,000	-6,576,000	19,144,000	18,857,000	17,542,000	-5,792,000															-1,179,000	-6,389,000	4,975,000	-2,300,000	-432,000	-1,837,000	4,103,000	2,996,000	-4,223,000	352,000			-5,677,000	-8,309,000	1,492,000	-1,464,000	-1,849,000	-5,332,000	-2,782,000	-2,475,000	4,962,000	10,060,000	8,477,000	-4,744,000	-1,432,000	-2,374,000	-1,955,000	694,000	-902,000	-3,019,000	415,000	-2,550,000	1,685,000	-3,696,000	-2,901,000	-2,199,000	-2,320,000	1,599,000	-2,169,000	720,000	-4,243,000	-1,867,000	-330,000	-1,573,000
prepaid expenses and other current assets	-4,188,000	245,000	1,670,000	7,734,000	-14,592,000	-1,054,000	9,750,000	-846,000	-2,160,000	-6,765,000															1,186,000	-29,000	-1,760,000	1,303,000	171,000	-457,000	2,480,000	-30,000	-1,389,000	-557,000			-1,632,000	-2,397,000	1,842,000	-1,015,000	-281,000	-1,360,000	-3,412,000	-198,000	3,447,000	34,000	682,000	22,000	2,152,000	-3,037,000	1,872,000	-761,000	-116,000	-873,000	2,882,000	-573,000	-119,000	-2,330,000	2,224,000	-1,892,000	-562,000	391,000	3,778,000	-741,000	-550,000	-2,768,000	-2,235,000	383,000
accrued restructuring	-6,901,000	-9,045,000	-1,198,000	-1,955,000
accounts payable and accrued liabilities	-9,839,000	-15,712,000	16,975,000	-591,000	-1,621,000	-23,400,000	3,891,000	13,958,000	-18,380,000	6,468,000															-3,329,000	-544,000	-1,955,000	9,606,000	2,776,000	874,000	-831,000	-4,756,000	1,087,000	1,938,000			2,082,000	4,455,000	504,000	-1,402,000	12,227,000	-5,818,000	6,267,000	16,627,000	-309,000	-6,045,000	-28,680,000	4,934,000	5,134,000	-9,280,000	1,603,000	2,886,000	374,000	2,749,000	-2,911,000	6,876,000	1,230,000	245,000	10,377,000	2,631,000	8,113,000	-5,395,000	-1,667,000	2,009,000	-542,000	329,000	2,713,000	232,000
net cash from operating activities	41,572,000	-3,050,000	63,064,000	67,980,000	46,303,000	27,231,000	79,560,000	83,408,000	78,270,000	37,782,000															10,051,000	-1,797,000	21,849,000	24,457,000	16,189,000	11,306,000	21,123,000	19,829,000	15,209,000	6,732,000			7,266,000	-7,099,000	18,037,000	9,215,000	15,064,000	-4,769,000	6,868,000	7,948,000	18,590,000	8,197,000	2,392,000	2,882,000	14,309,000	-6,192,000	11,116,000	19,251,000	2,162,000	-5,028,000	4,823,000	8,816,000			9,225,000	-5,618,000			522,000				7,074,000	3,488,000
cash flows from investing activities
investments in property, plant and equipment	-7,960,000	-12,329,000	-22,457,000	-8,213,000	-6,664,000	-4,460,000	-13,006,000	-8,754,000	-10,879,000	-6,161,000															-2,464,000	-3,057,000	-4,109,000	-2,128,000	-2,479,000	-2,723,000		-2,334,000	-3,245,000	-3,178,000			-3,166,000	-3,475,000		-2,791,000	-1,426,000	-2,042,000		-4,733,000	-2,703,000	-2,375,000		-2,160,000	-5,089,000	-1,949,000		-1,251,000	-1,459,000	-2,721,000			-3,208,000	-1,655,000		-1,946,000	-1,568,000	-1,628,000		-1,895,000	-2,568,000	-2,347,000		-2,961,000
payments related to acquisitions, net of cash acquired	-160,095,000	-3,983,000	0	-14,403,000	0	-24,899,000																					0	0	-1,831,000	-647,000	-3,000,000
proceeds from disposition of assets	50,000	2,900,000	1,878,000	0	2,740,000	58,000																			70,000	58,000	122,000	46,000	332,000	13,000	52,000	109,000	20,000	64,000			51,000	170,000	82,000	88,000	18,000	41,000	26,000	23,000	12,000	1,605,000	38,000	22,000	52,000	65,000	83,000	70,000			0	18,000			24,000	1,224,000	23,000	647,000
other investing activities
net cash from investing activities	-167,308,000	-13,412,000	-20,579,000	-22,616,000	-3,924,000	-29,301,000	-1,827,000	-8,754,000	-10,879,000	-6,161,000															-1,751,000	-2,662,000	-3,730,000	-1,735,000	-3,594,000	-3,357,000	-6,609,000	-4,594,000	-2,900,000	-2,631,000			-3,333,000	-2,940,000	-31,645,000	-9,112,000	-574,000	295,000	-3,021,000	-1,637,000	-1,154,000	-800,000	-1,746,000	-1,842,000	-13,813,000	-2,748,000	-3,893,000	-844,000	-1,232,000	-3,456,000	-4,189,000	-3,537,000
cash flows from financing activities
payments of long-term debt	-8,682,000	-8,523,000	-8,621,000	-14,431,000	-29,458,000	-4,711,000	-24,857,000	-4,636,000	-4,736,000	-4,703,000
borrowings on revolving credit facilities	186,000,000	30,000,000
payments on other debt	672,000	-773,000							13,000	-469,000
dividends paid	-8,574,000	-8,572,000	-8,647,000	-8,151,000	-8,186,000	-8,186,000	-8,191,000	-7,828,000	-7,822,000	-7,809,000															-3,307,000	-3,300,000	-3,297,000	-3,293,000	-3,220,000	-3,208,000	-3,206,000	-3,197,000	-3,108,000	-3,105,000			-2,712,000	-2,701,000	-2,681,000	-2,649,000	-2,569,000	-2,550,000	-2,546,000	-2,543,000	-2,530,000	-2,492,000	-2,509,000	-2,444,000	-2,369,000	-2,181,000	-2,170,000	-2,180,000	-2,167,000	-2,137,000	-2,124,000	-2,121,000	-2,109,000	-2,090,000	-2,089,000	-2,088,000	-2,084,000	-2,079,000	-2,071,000	-2,079,000	-2,071,000	-2,020,000	-2,007,000	-1,985,000
shares purchased under share repurchase programs				-15,146,000
other stock related activity	-125,000	-1,176,000	-1,752,000	861,000	-50,000	-1,442,000		-241,000	1,397,000	-2,109,000
net cash from financing activities	136,598,000	10,956,000	-55,662,000	-27,705,000	-45,860,000	6,563,000	-88,081,000	-61,509,000	-64,150,000	-24,866,000															-8,521,000	-3,498,000	-4,471,000	-8,280,000	-8,713,000	-4,742,000	-12,765,000	-10,274,000	-4,816,000	-2,686,000			-4,460,000	7,096,000	12,714,000	-4,806,000	-8,938,000	5,367,000	-4,160,000	-6,423,000	-12,048,000	-10,186,000	-2,820,000	2,704,000	950,000	8,520,000	-11,986,000	-9,580,000	2,471,000	3,192,000				7,264,000	-4,213,000	1,289,000	-9,412,000	-2,510,000	-4,803,000	2,430,000	4,329,000	5,424,000	9,167,000	7,951,000
effect of foreign exchange rate changes on cash	4,833,000	2,849,000	-10,017,000	5,847,000	-3,701,000	-3,270,000	6,517,000	-4,192,000	-3,708,000	2,154,000						1,743,000	1,452,000	1,563,000	195,000
net increase in cash and cash equivalents	15,695,000	-2,657,000	-23,194,000	23,506,000	-7,182,000	1,223,000	-3,831,000	8,953,000																	-218,000	-8,042,000	14,547,000	15,399,000	3,290,000	2,709,000	2,375,000	4,920,000	6,288,000	2,055,000					-1,383,000	-457,000			-318,000	764,000	6,628,000	-2,915,000	-3,174,000	1,896,000	1,643,000	332,000	-4,029,000								3,012,000	-3,998,000	-991,000	-10,980,000	-870,000	5,478,000	1,576,000	979,000	3,934,000	2,883,000
cash and cash equivalents at the beginning of the period	0	188,880,000	0	0	0	194,527,000	0	0	0	180,963,000
cash and cash equivalents at the end of the period	15,695,000	186,223,000	-23,194,000	23,506,000	-7,182,000	195,750,000	-3,831,000	8,953,000	-467,000	189,872,000
supplemental cash flow disclosures:
non-cash activities:
change in accrued purchases of property, plant and equipment	1,714,000	-7,105,000
(gain) loss on disposal of property, plant and equipment and other assets		-2,148,000
amortization of debt issuance costs			354,000	353,000	353,000	353,000	354,000	353,000	353,000	353,000
uncertain tax positions
deferred compensation and other			6,295,000																						396,000	2,944,000	-209,000	1,030,000	-219,000	-861,000	-2,004,000	516,000	1,435,000	-103,000			2,195,000	1,967,000	-2,187,000	1,916,000	-646,000	289,000	682,000	1,491,000	1,331,000	-2,852,000	-21,000	-1,658,000	2,476,000	22,000	-963,000	54,000	557,000	267,000	-894,000	326,000	245,000	-184,000	-1,114,000	791,000	-90,000	388,000	-1,042,000	758,000	37,000	208,000
loss on extinguishment of debt
gain on disposal of property, plant, equipment and other assets
pension and other postretirement benefits			-504,000	-2,962,000	-443,000	-551,000	-79,000	-1,692,000	107,000	-415,000															739,000	-1,665,000	1,423,000	1,323,000	637,000	-2,521,000	396,000	128,000	406,000	-2,357,000			742,000	-4,910,000	548,000	-957,000	38,000	-2,265,000	-2,052,000	-2,078,000	-1,892,000	-1,907,000	14,000	-230,000	-853,000	-2,458,000	-1,064,000	-759,000	-904,000	-869,000	-1,139,000	-356,000	-887,000	-1,865,000	3,466,000	-3,537,000	-161,000	-207,000	-825,000	242,000	98,000	313,000
estimated taxes on income
proceeds from long-term debt																																		1,350,000				10,000,000	9,812,000			7,583,000	0	1,916,000	0	1,584,000	0	0	156,000	9,844,000													101,000	0
borrowings (payments) on revolving credit facilities			-12,584,000	9,967,000	-369,000	20,902,000
borrowings (payments) on other debt
financing-related debt issuance costs
shares purchased under share repurchase program
cash paid during the year for:
income taxes, net of refunds
interest
(payments) borrowings on other debt
deferred compensation, deferred taxes and other					-1,215,000	568,000		-669,000	2,385,000	-2,231,000
decrease in cash from changes in current assets and current liabilities, net of acquisitions:
change in restructuring liabilities						-3,666,000	-1,872,000	-2,504,000	-2,663,000	-2,747,000																																	-233,000	-355,000	-1,233,000	-2,652,000									-302,000	-320,000	-499,000	-2,912,000		-254,000	-742,000	-640,000	-78,000	-153,000	-37,000	-290,000	-175,000	-42,000
acquisition-related fair value adjustments related to inventory
combination and other acquisition-related expenses, net of payments
(repayments) borrowings on revolving credit facilities
repayments on other debt
stock options exercised, other																									172,000	-205,000	203,000	-594,000	143,000	-59,000	-96,000	97,000	363,000	-1,288,000			196,000	-50,000	1,671,000	2,166,000	1,528,000	135,000	59,000	91,000	193,000	69,000	-2,055,000	6,346,000	6,142,000	1,486,000	374,000	330,000	796,000	1,809,000					142,000	113,000			191,000	102,000	484,000	232,000
restructuring and related charges (credits)
payments on revolving credit facilities
borrowings on other debt
(payments) borrowings on revolving credit facilities									-53,002,000	-9,776,000
net decrease in cash and cash equivalents										8,909,000																												-2,202,000				-231,000											3,730,000	-5,275,000		3,674,000
(gain) loss on disposal of property, plant, equipment and other assets
insurance settlement realized																										-337,000		-347,000			-317,000	-266,000	-325,000	-483,000			-499,000	-365,000	-415,000	-453,000	-427,000	-345,000	-504,000	-494,000	-466,000	-144,000	-575,000	-296,000	-549,000	-136,000	-588,000	-353,000	-648,000	-265,000	-292,000	-95,000	-85,000	-72,000
gain on inactive subsidiary litigation and settlement reserve
insurance settlement interest earned																										11,000		12,000
purchase of noncontrolling interest in affiliates
distributions to noncontrolling affiliate shareholders
net increase in cash, cash equivalents and restricted cash											192,396,000	-4,905,000		-32,312,000
cash, cash equivalents and restricted cash at the beginning of the period											143,555,000	0	124,425,000	124,425,000
cash, cash equivalents and restricted cash at the end of the period											335,951,000	-4,905,000	106,458,000	92,113,000
balance as of december 31, 2019
cumulative effect of an accounting change
balance as of january 1, 2020
amounts reported in other comprehensive income
dividends declared
acquisition of noncontrolling interest
shares issued upon exercise of stock options and other
share-based compensation plans
balance as of december 31, 2020
balance as of december 31, 2021
balance as of december 31, 2022
increase in cash from changes in current assets and current
cash transferred to houghton shareholders											170,829,000
cash paid to extinguish houghton debt obligations											702,556,000
fair value of common stock issued as consideration											789,080,000
balance as of december 31, 2016
dividends
shares issued upon exercise of stock options
shares issued for employee stock purchase plan
share based compensation plans
balance as of december 31, 2017
balance as of january 1, 2018
amounts reported in other comprehensive loss
distributions to noncontrolling affiliate
balance as of december 31, 2018
balance as of january 1, 2019
shares issued related to the combination
net decrease in cash, cash equivalents and restricted cash													-17,967,000
north
america
net sales													53,150,000	56,288,000
customer industries
primary metals													24,723,000	24,883,000
metalworking													26,740,000	28,248,000
coatings and other													1,687,000	3,157,000
timing of revenue recognized
product sales at a point in time													53,098,000	56,234,000
services transferred over time													52,000	54,000
effect of exchange rate changes on cash																					1,421,000	-2,923,000	197,000	-1,708,000	3,000	-85,000	899,000	957,000	-592,000	-498,000	626,000	-41,000	-1,205,000	640,000	-1,395,000	-2,165,000	504,000	741,000	-489,000	4,246,000	-2,766,000	-1,124,000	-5,000	876,000	1,240,000	-126,000	-1,000,000	-1,848,000	197,000	752,000	734,000	880,000	329,000	17,000	461,000	259,000	-112,000	448,000	-177,000	1,053,000	-757,000	-971,000	3,477,000	317,000	-491,000	-327,000	1,275,000	207,000
north america
emea
asia/pacific
south america
total net sales
operating earnings, excluding indirect operating expenses
total operating earnings, excluding indirect operating expenses
indirect operating expenses
amortization expense
consolidated operating income
other income
interest expense
interest income
consolidated income before taxes and equity in net income of
associated companies
common
stock
balance at december 31, 2011
equity based compensation plans
excess tax benefit from stock option exercises
balance at december 31, 2012
adjustment to prior period earnings
balance at december 31, 2013
acquisition of noncontrolling interests
balance at december 31, 2014
depreciation																									3,009,000	3,075,000	3,120,000	3,094,000	3,069,000	3,056,000	3,251,000	3,032,000	2,912,000	3,057,000			2,749,000	2,656,000	2,419,000	2,380,000	2,475,000	2,593,000	2,577,000	2,147,000	2,343,000	2,458,000	2,600,000	2,822,000	2,777,000	2,680,000	3,107,000	3,079,000	2,781,000	2,719,000	2,730,000	2,513,000	2,398,000	2,495,000	2,432,000	2,183,000	2,280,000	2,268,000	2,338,000	2,174,000	2,117,000	1,981,000	1,431,000	1,852,000
amortization																									815,000	813,000	824,000	858,000	884,000	879,000	823,000	818,000	719,000	746,000			487,000	486,000	252,000	274,000	208,000	254,000	281,000	275,000	265,000	257,000	271,000	300,000	306,000	300,000	297,000	289,000	272,000	339,000	369,000	350,000	357,000	351,000	354,000	368,000	340,000	306,000	294,000	288,000	291,000	284,000	340,000	182,000
stock-based compensation																									1,344,000	1,388,000	1,028,000	981,000	1,112,000	1,040,000	853,000	876,000	892,000	1,186,000			986,000	868,000	725,000	708,000	936,000	727,000	545,000	658,000	575,000	352,000	259,000	1,880,000	1,386,000	376,000	687,000	302,000	299,000	262,000		216,000	214,000	171,000
gain on disposal of property, plant and equipment																									-49,000	-48,000	7,000	417,000	-222,000	-2,000		-62,000	1,000	-14,000			-38,000	-40,000	56,000	-2,000	10,000	-32,000	-8,000	-1,000	0	-1,193,000
insurance settlements realized
interest earned on insurance settlements
change in restricted cash																									631,000	326,000	245,000	335,000	370,000	-14,000	301,000	248,000	308,000	465,000			479,000	343,000	392,000	424,000	802,000	-2,742,000	1,911,000	3,009,000	1,493,000	-4,086,000	1,547,000	240,000	-8,842,000	-4,976,000	417,000	145,000	-4,535,000	122,000	-7,304,000	9,000	6,000	-3,000
repayment of long-term debt																									-16,000	-232,000	-502,000	-4,726,000	-5,125,000	-2,438,000	-7,960,000	-7,918,000	-1,565,000	-189,000			-40,171,000	-231,000				-122,000				-7,728,000				-251,000				-225,000				-233,000	-238,000	-8,810,000	-236,000	-282,000	-3,380,000	-44,000	-95,000	-160,000
excess tax benefit related to stock option exercises																									28,000	239,000	0	363,000	83,000	369,000	-119,000	744,000	874,000	546,000			84,000	78,000	264,000	1,058,000	915,000	321,000
purchase of a noncontrolling interest in an affiliate
payment of acquisition-related earnout liability
cash and cash equivalents at beginning of period																									0	68,492,000	0	0	0	32,547,000	0	0	0	16,909,000			0	25,766,000		0	0	25,051,000		0	0	20,892,000		0	0	20,195,000		0	0	16,062,000		0	0	16,121,000		0	0	29,078,000		0	0	21,915,000		0
cash and cash equivalents at end of period																									-218,000	60,450,000	14,547,000	15,399,000	3,290,000	35,256,000	2,375,000	4,920,000	6,288,000	18,964,000			-23,000	23,564,000		-457,000	2,786,000	24,820,000		764,000	6,628,000	17,977,000		1,896,000	1,643,000	20,527,000		9,707,000	3,730,000	10,787,000		3,674,000	2,506,000	9,605,000		-3,998,000	-991,000	18,098,000		5,478,000	1,576,000	22,894,000		2,883,000
consolidated income before taxes and equity in net income of associated companies
net increase in short-term borrowings																														594,000																								-1,262,000				-2,504,000	-60,518,000	13,032,000	-7,281,000	2,064,000	2,067,000	4,451,000	3,548,000	7,617,000	13,895,000	8,939,000
acquisition-related fair value adjustments
interest earned on an insurance settlement
net decrease in short-term borrowings																																												-80,000	-97,000	-1,619,000		99,000	-1,110,000	-378,000
proceeds from sale of common stock, net of related expenses
dividends paid to noncontrolling shareholders
income taxes
accrued purchases of property, plant and equipment
balance at december 31, 2010
dividends paid to noncontrolling interests
stock offering, net of related expenses
distributions to noncontrolling shareholders																															-1,069,000	0											-616,000	-184,000
accrued property, plant and equipment purchases																												19,000
asia pacific
assets
company-owned life insurance
company-owned life insurance - deferred compensation assets
other deferred compensation assets
large capitalization registered investment companies
mid capitalization registered investment companies
small capitalization registered investment companies
international developed and emerging markets registered investment
companies
fixed income registered investment companies
total
insurance settlement received and interest earned																														14,000	16,000	18,000	17,000	18,000			20,000	22,000	23,000	29,000	32,000	5,038,000	40,000	64,000	44,000	5,056,000	72,000	56,000	66,000	5,112,000	171,000	208,000
(gain) loss on disposal of property, plant and equipment																																															-7,000	73,000	-41,000	-35,000			1,000	5,000	15,000
capital expenditures																																																							-3,866,000
free cash flows																																																							957,000
restricted insurance receivable																																							0	0	0	5,000,000
property, plant and equipment acquired by capital lease
balance at december 31, 2009
currency translation adjustments
defined benefit retirement plans:
net income arising during the period, other
amortization of actuarial loss
amortization of prior service cost
amortization of initial net asset
current period changes in fair value of derivatives
unrealized gain on available-for-sale securities
unrealized loss on available-for-sale securities
non-cash gain from purchase of equity affiliate
•
equity in net (income) loss of associated companies, net of dividends																																						-262,000
restructuring and related activities																																											0	0	0	2,289,000													4,786,000	0	0	1,232,000
balance at december 31, 2008
defined benefit retirement plans
net gain arising during the period, other
comprehensive income
comprehensive loss attributable to noncontrolling interest
comprehensive income attributable to
quaker chemical corporation
equity in net income of associated companies, net of dividends																																										89,000								-112,000
cash and cash equivalents at beginning of the period
cash and cash equivalents at end of the period
supplemental cash flow disclosures
balance at december 31, 2007
amortization of actuarial (gain) loss
comprehensive loss
comprehensive income attributable to noncontrolling interest
comprehensive loss attributable to quaker chemical corporation
effects of adjustment to apply change of measurement date provisions of defined benefit retirement plans guidance:
service cost, interest cost and expected return on plan assets for december 1, 2007 – december 31, 2007, net of tax
amortization of prior service cost for december 1, 2007 – december 31, 2007, net of tax
shares issued upon exercise of options and other
equity-based compensation plans
comprehensive income attributable to quaker chemical corporation
payments related to acquisitions																																											-975,000	0	0	-1,000,000	-859,000	0	0	-1,000,000	-830,000	-16,000	-527,000	-1,000,000	-615,000	0	-69,000	-1,000,000	0	0	0	-6,700,000					-9,246,000	-5,632,000
repayments of long-term debt																																								-2,753,000				-5,623,000				-1,045,000				-226,000				-230,000
environmental charges																																																			0
proceeds from short-term debt
balance at december 31, 2006																																																			-1,082,494,000	0	0	1,092,420,000
adjustment to initially apply uncertain tax position guidance
shares issued upon exercise of options
2008 4th quarter program:
restructuring charges																																												0
payments																																												0
currency translation																																												0
december 31, 2008 ending balance																																												0
march 31, 2009 ending balance																																												0
june 30, 2009 ending balance																																												0
september 30, 2009 ending balance
2009 1st quarter program:
total accrued restructuring ending balances as of september 30, 2009
total accrued restructuring ending balances as of june 30, 2009 ending balance
equity in net income (income) of associated companies, net of dividends																																														142,000
minority interest in earnings of subsidiaries																																															67,000	266,000	211,000	364,000	253,000	350,000	428,000	348,000	289,000	312,000	417,000	304,000	131,000	441,000	719,000	918,000	1,093,000	865,000	897,000	1,019,000	726,000	777,000
distributions to minority shareholders																																															-152,000				-401,000	-594,000	0	-270,000	-26,000	-1,114,000	0	-350,000	-1,035,000	-958,000	-1,000	-2,204,000	-1,711,000	0	0	-245,000	-1,373,000	-409,000
balance at december 31, 2005
minimum pension liability
adjustment to initially apply fasb statement no. 158
fasb statement no. 158:
adjustment to initially apply fin 48
effects of adjustment to apply change of measurement date provisions of fasb statement no. 158:
service cost, interest cost and expected return on plan assets for dec 1, 2007 – december 31, 2007, net of tax
short-term debt borrowings
gain on sale of partnership assets																																																											0	0	0	-2,989,000
proceeds from partnership disposition of assets																																																											0	0	0	2,989,000
balance at december 31, 2004
amortization of unearned compensation
loss on disposal of property, plant and equipment
repayments of short-term debt
long-term debt borrowings																																																				-7,789,000	5,644,000	5,277,000		1,340,000	2,000,000	12,340,000
options granted																																																				0	0	166,065,000
options exercised																																																				-15,100,000	-28,960,000	-122,875,000
options forfeited																																																				0
options expired																																																				-9,894,000	-500,000	-1,125,000
balance at september 30, 2007
exercisable at september 30, 2007
balance at june 30, 2007
exercisable at june 30, 2007
interest received on insurance settlement																																																						143,000		86,000	79,000	75,000
balance at march 31, 2007																																																						1,134,485,000
exercisable at march 31, 2007																																																						864,710,000
deferred income tax
stock based compensation
other																																																															-113,000	10,000	85,000	-57,000	30,000	-170,000
balance at december 31, 2003
issuance of common stock																																																								94,000	234,000	101,000
net cash from by financing activities																																																								-1,864,000
net income - as reported																																																								417,000
add: stock-based employee compensation expense included in net income, net of related tax effects																																																								155,000	-38,000	78,000		155,000	-38,000	78,000				102,000		217,000
deduct: total stock-based employee compensation expense determined under the fair value based method for all awards, net of tax																																																								174,000	-100,000	-304,000		174,000	-100,000	-304,000		-185,000	20,000	-176,000		-253,000
pro forma net income																																																								746,000	-1,469,000	2,900,000		746,000	-1,469,000	2,900,000		-1,714,000	-544,000	3,235,000		625,000
earnings per share:
basic - as reported																																																								40
basic - pro forma																																																								70
diluted - as reported																																																								50
diluted - pro forma																																																								70
net cash (used in) operating activities																																																										-11,645,000				-2,807,000			221,000	-1,947,000
net cash (used in) investing activities																																																										-2,583,000	-1,823,000	-722,000	-1,311,000	-4,692,000	-66,000	-1,830,000	-2,483,000	-2,171,000	-13,582,000	-8,763,000
net (decrease) in cash and cash equivalents																																																										-6,516,000
net income – as reported																																																										3,126,000		417,000	-1,331,000	3,126,000		-1,693,000	-462,000	3,309,000		661,000
basic – as reported																																																										320		40	-130	320		-180	-50	350		70
basic – pro forma																																																										300		70	-150	300		-180	-60	340		60
diluted – as reported																																																										320		50	-140	320		-170	-40	330		60
diluted – pro forma																																																										290		70	-140	290		-170	-50	320		50
equity in net income of associated companies																																																											-204,000	-208,000	-153,000	-53,000	-291,000	-264,000	-186,000	-149,000	-374,000	-215,000
gain on sale of property, plant, and equipment
restructuring liabilities
dividends and distributions from associated companies																																																											0	0			0	55,000	0	233,000	190,000	0
insurance settlement received
investment in restricted cash
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
balance at december 31, 2002
shares issued for long-term incentive awards
compensation plan
adjustments to reconcile net income to net cash from provided by operating activities:
balance at december 31, 2001
unrealized (loss) on available-for-sale securities
adjustments to reconcile net income to net cash (used in) operating activities:
increase in cash from changes in current assets and current liabilities:
environmental charge
investments in and advances to associated companies
treasury stock issued																																																																			1,222,000	1,409,000
noncash investing activities:
contribution of property, plant, and equipment to real estate joint venture
balance at december 31, 2000
restricted stock grant of 1,774, amortization of unearned compensation of 177
deferred compensation and other postretirement benefits																																																																				639,000
pension and other																																																																				197,000

We provide you with 20 years of cash flow statements for Quaker Chemical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Quaker Chemical stock. Explore the full financial landscape of Quaker Chemical stock with our expertly curated income statements.

The information provided in this report about Quaker Chemical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.